Cargando…

VEGF Overexpression Is a Valuable Prognostic Factor for Non-Hodgkin's Lymphoma Evidence from a Systemic Meta-Analysis

Vascular endothelial growth factor (VEGF) plays a vital role in the progression of Non-Hodgkin's lymphoma (NHL). Although multiple studies have investigated the relationship between VEGF expression and prognosis of NHL, these studies have yielded conflicting results. Therefore, we performed a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Li, Wenlu, He, Xin, Zhang, Guofei, Yue, Lan, Chai, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355555/ https://www.ncbi.nlm.nih.gov/pubmed/25810565 http://dx.doi.org/10.1155/2015/786790

Ejemplares similares

Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
por: Jiang, Yangyan, et al.
Publicado: (2015)

Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
por: Jiang, Yangyan, et al.
Publicado: (2016)

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
por: He, Xin, et al.
Publicado: (2014)

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis
por: Zeng, Qiang, et al.
Publicado: (2020)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
por: Chohan, Karan L., et al.
Publicado: (2022)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis
por: Zhao, Shu, et al.
Publicado: (2018)

VEGF and bFGF Gene Polymorphisms in Patients with Non-Hodgkin's Lymphoma
por: Wróbel, Tomasz, et al.
Publicado: (2013)

Evidence of Inbreeding in Hodgkin Lymphoma
por: Thomsen, Hauke, et al.
Publicado: (2016)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
por: Lee, Shing Fung, et al.
Publicado: (2019)

Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma
por: Kischel, Philippe, et al.
Publicado: (2011)

The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers
por: Ahmed, Rehana, et al.
Publicado: (2022)

Overexpression of VEGF in Testis and Epididymis Causes Infertility in Transgenic Mice: Evidence for Nonendothelial Targets for VEGF
por: Korpelainen, Eija I., et al.
Publicado: (1998)

Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma
por: Yang, Jing, et al.
Publicado: (2022)

Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
por: Guo, Baoping, et al.
Publicado: (2016)

Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis
por: Yang, Jia, et al.
Publicado: (2017)

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B(5b )(CYB5B)
por: Murphy, Derek, et al.
Publicado: (2010)

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?
por: Child, J. A.
Publicado: (1991)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023)

Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis
por: Li, Xiao-Mei, et al.
Publicado: (2017)

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
por: Hu, Jianyu, et al.
Publicado: (2022)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma
por: Heckmann, Markus B., et al.
Publicado: (2019)

Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review
por: Donato, Eva M, et al.
Publicado: (2018)

Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
por: Javanmardi, Fatemeh, et al.
Publicado: (2018)

Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma
por: Kuang, Zhixing, et al.
Publicado: (2021)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
por: Georgoulis, Vasileios, et al.
Publicado: (2023)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

PB2435: ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES IN HODGKIN LYMPHOMA: A PROGNOSTIC STUDY OF 30 PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
por: Zamani, Shayan, et al.
Publicado: (2023)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors
por: Huang, JiaJia, et al.
Publicado: (2010)

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
por: Yao, Shuyan, et al.
Publicado: (2021)

Association of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: Evidence from a meta-analysis
por: He, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l0f0mgb3qp5uldhi16snmrfjh5